Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Cancer Targeted Technology gets NIH grant to support CTT1403 trial Cancer Targeted Technology (CTT), a Seattle-based biotech company, has secured a grant of $1.44 million from the US… bypharmanewsdailyAugust 7, 2020